Fingerprint
Dive into the research topics of 'A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically